Your browser doesn't support javascript.
loading
Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials.
López-Fauqued, Marta; Campora, Laura; Delannois, Frédérique; El Idrissi, Mohamed; Oostvogels, Lidia; De Looze, Ferdinandus J; Diez-Domingo, Javier; Heineman, Thomas C; Lal, Himal; McElhaney, Janet E; McNeil, Shelly A; Yeo, Wilfred; Tavares-Da-Silva, Fernanda.
Afiliación
  • López-Fauqued M; GSK, Wavre, Belgium. Electronic address: marta.x.lopez-fauqed@gsk.com.
  • Campora L; GSK, Wavre, Belgium. Electronic address: laura.e.campora@gsk.com.
  • Delannois F; GSK, Wavre, Belgium. Electronic address: frederique.x.delannois@gsk.com.
  • El Idrissi M; GSK, Rixensart, Belgium. Electronic address: mohamed.s.elidrissi@gsk.com.
  • Oostvogels L; GSK, Wavre, Belgium. Electronic address: cornelia.oostvogels@orange.fr.
  • De Looze FJ; AusTrials Pty Ltd, Sherwood and School of Medicine, University of Queensland, Brisbane, Queensland, Australia. Electronic address: f.delooze@trialworks.com.au.
  • Diez-Domingo J; Vaccine Research Unit, Fundación para el Fomento de la Investigación Sanitaria y Biomédica, Valencia, Spain. Electronic address: jdiezdomingo@gmail.com.
  • Heineman TC; GSK, King of Prussia, PA, USA. Electronic address: tch3768@gmail.com.
  • Lal H; GSK, King of Prussia, PA, USA. Electronic address: himallal@yahoo.com.
  • McElhaney JE; Health Sciences North Research Institute, Sudbury, Ontario, Canada. Electronic address: jmcelhaney@hsnri.ca.
  • McNeil SA; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: Shelly.McNeil@nshealth.ca.
  • Yeo W; School of Medicine, University of Wollongong, Wollongong, Australia. Electronic address: wilf@uow.edu.au.
  • Tavares-Da-Silva F; GSK, Wavre, Belgium. Electronic address: fernanda.tavares@gsk.com.
Vaccine ; 37(18): 2482-2493, 2019 04 24.
Article en En | MEDLINE | ID: mdl-30935742
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Sintéticas / Vacuna contra el Herpes Zóster / Herpes Zóster Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Vaccine Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Sintéticas / Vacuna contra el Herpes Zóster / Herpes Zóster Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Vaccine Año: 2019 Tipo del documento: Article